Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study
Abstract Introduction Studies that examine the association between sickle cell disease (SCD) and COVID‐19 outcomes are lacking. This study aims to determine whether SCD is a risk factor for severe COVID‐19 infection in regard to the requirement of noninvasive ventilation/high flow nasal cannula (NIV...
Main Authors: | Abdulkarim Abdulrahman, Mohammed Wael, Fajer AlAmmadi, Zahra Almosawi, Reem Alsherooqi, Manal Abduljalil, Nitya Kumar, Manaf AlQahtani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.170 |
Similar Items
-
The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease
by: F. Moreira Neto, et al.
Published: (2006-10-01) -
Minimal doses of hydroxyurea for sickle cell disease
by: C.S.P. Lima, et al.
Published: (1997-08-01) -
Sickle cell anemia in Brazil: personal, medical and endodontic patterns
by: Shirlene Barbosa Pimentel FERREIRA, et al.
Published: (2016-01-01) -
Sickle cell disease presenting in the third trimester of pregnancy: Delayed detection heralding a public health problem?
by: Ankita Sharma, et al.
Published: (2020-01-01) -
Newborn screening for sickle cell anemia in Antalya, Türkiye
by: Zeynep Öztürk, et al.
Published: (2023-12-01)